Barclays’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-5,467
| Closed | -$3K | – | 4287 |
|
|
2016
Q2 | $3K | Buy |
+5,467
| New | +$3K | ﹤0.01% | 3251 |
|
|
2015
Q4 | – | Sell |
-244
| Closed | -$1K | – | 4356 |
|
|
2015
Q3 | $1K | Sell |
244
-651
| -73% | -$2.67K | ﹤0.01% | 3935 |
|
|
2015
Q2 | $8K | Sell |
895
-337
| -27% | -$3.01K | ﹤0.01% | 3430 |
|
|
2015
Q1 | $9K | Sell |
1,232
-954
| -44% | -$6.97K | ﹤0.01% | 3468 |
|
|
2014
Q4 | $11K | Buy |
2,186
+1,817
| +492% | +$9.14K | ﹤0.01% | 3725 |
|
|
2014
Q3 | $2K | Sell |
369
-411
| -53% | -$2.23K | ﹤0.01% | 4193 |
|
|
2014
Q2 | $5K | Buy |
780
+641
| +461% | +$4.11K | ﹤0.01% | 3927 |
|
|
2014
Q1 | $1K | Buy |
+139
| New | +$1K | ﹤0.01% | 4268 |
|
|
2013
Q4 | – | Sell |
-2,200
| Closed | -$7K | – | 4602 |
|
|
2013
Q3 | $7K | Buy |
+2,200
| New | +$7K | ﹤0.01% | 3745 |
|